Stock Events

Stock Events

Search...

Brainstorm Cell Therapeutics (BCLI) Q2 2025 Earnings

15MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-0.97

-0.45

0.08

0.6

Details

Expected EPS

-0.97

Actual EPS

-0.45

Surprise EPS

0.52

Surprise Percent

+53.61%

Description

Brainstorm Cell Therapeutics (BCLI) has reported earnings of -0.45 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.